Trial Profile
A Double-blind, Phase III, Multicenter, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Levetiracetam as Adjunctive Therapy, in Partial Seizures Control Associated With Refractory Focal Epilepsy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Mar 2016
Price :
$35
*
At a glance
- Drugs Levetiracetam (Primary)
- Indications Partial epilepsies
- Focus Therapeutic Use
- Acronyms Mozart
- 07 Mar 2016 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 15 Jul 2011 New trial record